Qube Research & Technologies Ltd

Position in STRO — Sutro Biopharma, Inc.

CIK 1729829 LONDON, X0

Position in STRO

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$3,539,452

+$3,482,706 QoQ

Shares Held

106,610

+1534.4% QoQ

Ownership

0.643%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#32

of 97 holders

Holding Since

Mar 2021

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Qube Research & Technologies Ltd holds $2,443,068,185 across 169 Biotechnology names. STRO ranks #88 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ALNY	Alnylam Pharmaceuticals, Inc.	798,715	$240,437,176
2	INSM	INSMED Inc	1,682,334	$179,370,451
3	REGN	Regeneron Pharmaceuticals, Inc.	221,607	$138,180,828
4	ROIV	Roivant Sciences Ltd.	3,454,496	$122,254,613
5	AXSM	Axsome Therapeutics, Inc.	426,336	$104,354,262
6	APGE	Apogee Therapeutics, Inc.	659,678	$87,559,060
7	TVTX	Travere Therapeutics, Inc.	1,443,230	$81,989,896
8	RPRX	Royalty Pharma plc	1,412,112	$79,177,119

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$3,539,452	106,610	+63.4%	Shares	Sole	2026-08-14
2025-09-30	$56,746	65,226	-43.5%	Shares	Sole	2025-11-14
2025-06-30	$81,934	115,401	+67.5%	Shares	Sole	2025-08-14
2024-09-30	$238,387	68,898	-2.4%	Shares	Sole	2024-11-14
2024-06-30	$206,899	70,614	+1325.7%	Shares	Sole	2024-08-14
2023-09-30	$17,186	4,953	-87.5%	Shares	Sole	2023-11-13
2023-03-31	$183,099	39,632	+35.3%	Shares	Sole	2023-05-15
2022-06-30	$152,642	29,298	+190.3%	Shares	Sole	2022-08-15
2021-12-31	$150,168	10,092	-34.2%	Shares	Sole	2022-02-10
2021-06-30	$285,152	15,339	+34.0%	Shares	Sole	2021-08-13
2021-03-31	$260,533	11,447	—	Shares	Sole	2021-05-14
No filing history on record for this holder in this stock.